Canadian cannabis company Green Organic Dutchman raises C$76 million in bought deal

Canadian cannabis company Green Organic Dutchman raises C$76 million in bought deal
Canadian cannabis company The Green Organic Dutchman Holdings Ltd. TGODF, -6.73% TGOD, -4.71% said Friday it has raised 76 million Canadian dollars ($99 million) in a capital raising to fund its expansion plans. The company closed a bought deal that involved the sale of 10.9 million units and 1.5 million warrants at a price per unit of C$6.85. The offering... Read More

Car crashes rise in states where marijuana is legal relative to states where it isn’t–IIHS-HDLI

Car crashes rise in states where marijuana is legal relative to states where it isn’t–IIHS-HDLI
Car crashes are up by as much as 6% in the four states in which recreational marijuana is legal, compared with neighboring states in which it is still illegal, according to report published Thursday by the Insurance Institute for Highway Safety (IIHS) and the Highway Loss Data Institute (HLDI). The report comes a day after cannabis became fully legal for... Read More

Cannabis company MedMen to sell ‘significant portion’ of real estate assets to Treehouse

Cannabis company MedMen to sell ‘significant portion’ of real estate assets to Treehouse
MedMen Enterprises Inc. MMNFF, -0.87% announced Thursday a deal to sell a “significant portion” of its real estate assets to Treehouse Real Estate Investment Trust, with the initial deal expected to generate about $12.5 million in proceeds after the repayment of debt. Additional properties are expected to be sold to Treehouse over the next 12 months. The properties sold to... Read More

Energy, IT Stocks Drag TSX Lower

Energy, IT Stocks Drag TSX Lower
The Canadian stock market ended modestly lower on Wednesday, after trading in negative territory right through the session, weighed down by lower commodity prices and largely sluggish U.S. and European markets. Information technology, energy and healthcare stocks were among the prominent losers. Industrial and materials stocks too were mostly weak. Financial stocks found modest support, while consumer discretionary and real... Read More

Canadian Shares May Open Lower

Canadian Shares May Open Lower
Lower index futures and commodity prices point to a weak opening for Canadian stocks on Wednesday. Activity is likely to be stock specific with investors tracking corporate news for direction. The market may move higher on expectations on the results front. However, worries about trade related issues may cap the market’s upside. Pot stocks are likely to see some hectic... Read More

Green Organic Dutchman’s stock surges after receipt of medical cannabis sales license

Green Organic Dutchman’s stock surges after receipt of medical cannabis sales license
Shares of Green Organic Dutchman Holdings Ltd. TGODF, -3.99% TGOD, -3.73% surged 5.3% in premarket trade Tuesday, after the organic medical cannabis company said it received its medical sales license from Health Canada. The license is in accordance with the Access to Cannabis for Medical Purposes Regulations for the Canada-based company’s Ancaster, Ontario facility. “As we prepare for our Founders... Read More

Tilray’s stock surges after Benchmark starts coverage with bullish rating, $200 target

Tilray’s stock surges after Benchmark starts coverage with bullish rating, $200 target
Shares of Tilray Inc. TLRY, +11.69% shot up 5.7% in premarket trade Tuesday, after Benchmark analyst Mike Hickey started coverage of the Canada-based medical cannabis and cannabinoid company with a buy rating and $200 price target. Hickey’s price target is 21% above Monday’s closing price $165.64. Hickey said his bullish view is based on the company’s early leadership in the... Read More

Krystal Bio Shines, CGC Hits Lifetime High, ANIX On Watch, CRON Gathers Steam

Krystal Bio Shines, CGC Hits Lifetime High, ANIX On Watch, CRON Gathers Steam
The following are some of today’s top gainers in the pharma/biotech sector. 1. Krystal Biotech Inc. (KRYS) Gained 27.55% to close Monday’s (Oct.15) trading at $20.00. News: The Company announced positive interim results from its ongoing placebo-controlled phase I/II clinical trial of KB103 to treat dystrophic epidermolysis bullosa, or DEB. DEB is an incurable, often fatal skin blistering condition caused... Read More

Canopy Growth to acquire IP and other assets of Colorado-based hemp company Ebbu

Canopy Growth to acquire IP and other assets of Colorado-based hemp company Ebbu
Canadian pot company Canopy Growth Corp. CGC, +5.64% WEED, +5.89% said Monday it has agreed to acquire the assets of Colorado-based Ebbu Inc., a hemp research company, for CAD25 million plus 6.2 million shares. The deal will “complement and accelerate multiple core verticals operating under Canopy Growth’s group of companies,” Canopy said in a statement. Canopy will take over IP... Read More